Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avigan in COVID-19 Patients With Mild Pneumonia
NCT04600999Phase 3Completed
- Sponsor
- University of Pécs
- Start
- Oct 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of favipiravir in coronavirus disease 2019 (COVID-19), sponsored by University of Pécs. Started Oct 2020; status: completed.
02
Drugs
favipiravir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04600999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04600999.